0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lyme Disease Testing Market Research Report 2026
Published Date: 2026-04-23
|
Report Code: QYRE-Auto-7U12861
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Lyme Disease Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Lyme Disease Testing Market Research Report 2026

Code: QYRE-Auto-7U12861
Report
2026-04-23
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lyme Disease Testing Market Size

The global Lyme Disease Testing market was valued at US$ 242 million in 2025 and is anticipated to reach US$ 375 million by 2032, at a CAGR of 6.6% from 2026 to 2032.

Lyme Disease Testing Market

Lyme Disease Testing Market

Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
This report delivers a comprehensive overview of the global Lyme Disease Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lyme Disease Testing. The Lyme Disease Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lyme Disease Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lyme Disease Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Lyme Disease Testing Market Report

Report Metric Details
Report Name Lyme Disease Testing Market
Accounted market size in 2025 US$ 242 million
Forecasted market size in 2032 US$ 375 million
CAGR 6.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • ELISA
  • Western Blotting
  • PCR
  • Others
Segment by Application
  • Hospital and Testing Agency
  • Personal
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), BioMerieux, Bio-Rad Laboratories, T2 Biosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Lyme Disease Testing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Lyme Disease Testing Market growing?

Ans: The Lyme Disease Testing Market witnessing a CAGR of 6.6% during the forecast period 2026-2032.

What is the Lyme Disease Testing Market size in 2032?

Ans: The Lyme Disease Testing Market size in 2032 will be US$ 375 million.

What is the market share of major companies in Lyme Disease Testing Market?

Ans: Global top three manufacturers hold a share about 25%.

What is the Lyme Disease Testing Market share by region?

Ans: North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.

Who are the main players in the Lyme Disease Testing Market report?

Ans: The main players in the Lyme Disease Testing Market are Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), BioMerieux, Bio-Rad Laboratories, T2 Biosystems

What are the Application segmentation covered in the Lyme Disease Testing Market report?

Ans: The Applications covered in the Lyme Disease Testing Market report are Hospital and Testing Agency, Personal

What are the Type segmentation covered in the Lyme Disease Testing Market report?

Ans: The Types covered in the Lyme Disease Testing Market report are ELISA, Western Blotting, PCR, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lyme Disease Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 ELISA
1.2.3 Western Blotting
1.2.4 PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lyme Disease Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital and Testing Agency
1.3.3 Personal
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyme Disease Testing Market Perspective (2021–2032)
2.2 Global Lyme Disease Testing Growth Trends by Region
2.2.1 Global Lyme Disease Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Lyme Disease Testing Historic Market Size by Region (2021–2026)
2.2.3 Lyme Disease Testing Forecasted Market Size by Region (2027–2032)
2.3 Lyme Disease Testing Market Dynamics
2.3.1 Lyme Disease Testing Industry Trends
2.3.2 Lyme Disease Testing Market Drivers
2.3.3 Lyme Disease Testing Market Challenges
2.3.4 Lyme Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lyme Disease Testing Players by Revenue
3.1.1 Global Top Lyme Disease Testing Players by Revenue (2021–2026)
3.1.2 Global Lyme Disease Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Lyme Disease Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Lyme Disease Testing Revenue
3.4 Global Lyme Disease Testing Market Concentration Ratio
3.4.1 Global Lyme Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lyme Disease Testing Revenue in 2025
3.5 Global Key Players of Lyme Disease Testing Head Offices and Areas Served
3.6 Global Key Players of Lyme Disease Testing, Products and Applications
3.7 Global Key Players of Lyme Disease Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Lyme Disease Testing Breakdown Data by Type
4.1 Global Lyme Disease Testing Historic Market Size by Type (2021–2026)
4.2 Global Lyme Disease Testing Forecasted Market Size by Type (2027–2032)
5 Lyme Disease Testing Breakdown Data by Application
5.1 Global Lyme Disease Testing Historic Market Size by Application (2021–2026)
5.2 Global Lyme Disease Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Lyme Disease Testing Market Size (2021–2032)
6.2 North America Lyme Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Lyme Disease Testing Market Size by Country (2021–2026)
6.4 North America Lyme Disease Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lyme Disease Testing Market Size (2021–2032)
7.2 Europe Lyme Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Lyme Disease Testing Market Size by Country (2021–2026)
7.4 Europe Lyme Disease Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Lyme Disease Testing Market Size (2021–2032)
8.2 Asia-Pacific Lyme Disease Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Lyme Disease Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Lyme Disease Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Lyme Disease Testing Market Size (2021–2032)
9.2 Latin America Lyme Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Lyme Disease Testing Market Size by Country (2021–2026)
9.4 Latin America Lyme Disease Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lyme Disease Testing Market Size (2021–2032)
10.2 Middle East & Africa Lyme Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Lyme Disease Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Lyme Disease Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Details
11.1.2 Quidel Corporation Business Overview
11.1.3 Quidel Corporation Lyme Disease Testing Introduction
11.1.4 Quidel Corporation Revenue in Lyme Disease Testing Business (2021–2026)
11.1.5 Quidel Corporation Recent Development
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Details
11.2.2 Roche Holding AG Business Overview
11.2.3 Roche Holding AG Lyme Disease Testing Introduction
11.2.4 Roche Holding AG Revenue in Lyme Disease Testing Business (2021–2026)
11.2.5 Roche Holding AG Recent Development
11.3 Fujirebio(H.U. Group Holdings)
11.3.1 Fujirebio(H.U. Group Holdings) Company Details
11.3.2 Fujirebio(H.U. Group Holdings) Business Overview
11.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Introduction
11.3.4 Fujirebio(H.U. Group Holdings) Revenue in Lyme Disease Testing Business (2021–2026)
11.3.5 Fujirebio(H.U. Group Holdings) Recent Development
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Details
11.4.2 ZEUS Scientific Business Overview
11.4.3 ZEUS Scientific Lyme Disease Testing Introduction
11.4.4 ZEUS Scientific Revenue in Lyme Disease Testing Business (2021–2026)
11.4.5 ZEUS Scientific Recent Development
11.5 IGeneX
11.5.1 IGeneX Company Details
11.5.2 IGeneX Business Overview
11.5.3 IGeneX Lyme Disease Testing Introduction
11.5.4 IGeneX Revenue in Lyme Disease Testing Business (2021–2026)
11.5.5 IGeneX Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Lyme Disease Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Lyme Disease Testing Business (2021–2026)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Everlywell
11.7.1 Everlywell Company Details
11.7.2 Everlywell Business Overview
11.7.3 Everlywell Lyme Disease Testing Introduction
11.7.4 Everlywell Revenue in Lyme Disease Testing Business (2021–2026)
11.7.5 Everlywell Recent Development
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Details
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Introduction
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Testing Business (2021–2026)
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Lyme Disease Testing Introduction
11.9.4 BioMerieux Revenue in Lyme Disease Testing Business (2021–2026)
11.9.5 BioMerieux Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Lyme Disease Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Lyme Disease Testing Business (2021–2026)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Details
11.11.2 T2 Biosystems Business Overview
11.11.3 T2 Biosystems Lyme Disease Testing Introduction
11.11.4 T2 Biosystems Revenue in Lyme Disease Testing Business (2021–2026)
11.11.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lyme Disease Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of ELISA
 Table 3. Key Players of Western Blotting
 Table 4. Key Players of PCR
 Table 5. Key Players of Others
 Table 6. Global Lyme Disease Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Lyme Disease Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Lyme Disease Testing Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Lyme Disease Testing Market Share by Region (2021–2026)
 Table 10. Global Lyme Disease Testing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Lyme Disease Testing Market Share by Region (2027–2032)
 Table 12. Lyme Disease Testing Market Trends
 Table 13. Lyme Disease Testing Market Drivers
 Table 14. Lyme Disease Testing Market Challenges
 Table 15. Lyme Disease Testing Market Restraints
 Table 16. Global Lyme Disease Testing Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Lyme Disease Testing Market Share by Players (2021–2026)
 Table 18. Global Top Lyme Disease Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lyme Disease Testing Revenue, 2025
 Table 19. Ranking of Global Top Lyme Disease Testing Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Lyme Disease Testing Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Lyme Disease Testing, Headquarters and Area Served
 Table 22. Global Key Players of Lyme Disease Testing, Products and Applications
 Table 23. Global Key Players of Lyme Disease Testing, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Lyme Disease Testing Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Lyme Disease Testing Revenue Market Share by Type (2021–2026)
 Table 27. Global Lyme Disease Testing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Lyme Disease Testing Revenue Market Share by Type (2027–2032)
 Table 29. Global Lyme Disease Testing Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Lyme Disease Testing Revenue Market Share by Application (2021–2026)
 Table 31. Global Lyme Disease Testing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Lyme Disease Testing Revenue Market Share by Application (2027–2032)
 Table 33. North America Lyme Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Lyme Disease Testing Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Lyme Disease Testing Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Lyme Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Lyme Disease Testing Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Lyme Disease Testing Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Lyme Disease Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Lyme Disease Testing Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Lyme Disease Testing Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Lyme Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Lyme Disease Testing Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Lyme Disease Testing Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Lyme Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Lyme Disease Testing Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Lyme Disease Testing Market Size by Country (US$ Million), 2027–2032
 Table 48. Quidel Corporation Company Details
 Table 49. Quidel Corporation Business Overview
 Table 50. Quidel Corporation Lyme Disease Testing Product
 Table 51. Quidel Corporation Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 52. Quidel Corporation Recent Development
 Table 53. Roche Holding AG Company Details
 Table 54. Roche Holding AG Business Overview
 Table 55. Roche Holding AG Lyme Disease Testing Product
 Table 56. Roche Holding AG Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 57. Roche Holding AG Recent Development
 Table 58. Fujirebio(H.U. Group Holdings) Company Details
 Table 59. Fujirebio(H.U. Group Holdings) Business Overview
 Table 60. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product
 Table 61. Fujirebio(H.U. Group Holdings) Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 62. Fujirebio(H.U. Group Holdings) Recent Development
 Table 63. ZEUS Scientific Company Details
 Table 64. ZEUS Scientific Business Overview
 Table 65. ZEUS Scientific Lyme Disease Testing Product
 Table 66. ZEUS Scientific Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 67. ZEUS Scientific Recent Development
 Table 68. IGeneX Company Details
 Table 69. IGeneX Business Overview
 Table 70. IGeneX Lyme Disease Testing Product
 Table 71. IGeneX Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 72. IGeneX Recent Development
 Table 73. Thermo Fisher Scientific Company Details
 Table 74. Thermo Fisher Scientific Business Overview
 Table 75. Thermo Fisher Scientific Lyme Disease Testing Product
 Table 76. Thermo Fisher Scientific Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 77. Thermo Fisher Scientific Recent Development
 Table 78. Everlywell Company Details
 Table 79. Everlywell Business Overview
 Table 80. Everlywell Lyme Disease Testing Product
 Table 81. Everlywell Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 82. Everlywell Recent Development
 Table 83. Oxford Immunotec Global PLC(PerkinElmer) Company Details
 Table 84. Oxford Immunotec Global PLC(PerkinElmer) Business Overview
 Table 85. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product
 Table 86. Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 87. Oxford Immunotec Global PLC(PerkinElmer) Recent Development
 Table 88. BioMerieux Company Details
 Table 89. BioMerieux Business Overview
 Table 90. BioMerieux Lyme Disease Testing Product
 Table 91. BioMerieux Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 92. BioMerieux Recent Development
 Table 93. Bio-Rad Laboratories Company Details
 Table 94. Bio-Rad Laboratories Business Overview
 Table 95. Bio-Rad Laboratories Lyme Disease Testing Product
 Table 96. Bio-Rad Laboratories Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 97. Bio-Rad Laboratories Recent Development
 Table 98. T2 Biosystems Company Details
 Table 99. T2 Biosystems Business Overview
 Table 100. T2 Biosystems Lyme Disease Testing Product
 Table 101. T2 Biosystems Revenue in Lyme Disease Testing Business (US$ Million), 2021–2026
 Table 102. T2 Biosystems Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Lyme Disease Testing Picture
 Figure 2. Global Lyme Disease Testing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Lyme Disease Testing Market Share by Type: 2025 vs 2032
 Figure 4. ELISA Features
 Figure 5. Western Blotting Features
 Figure 6. PCR Features
 Figure 7. Others Features
 Figure 8. Global Lyme Disease Testing Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Lyme Disease Testing Market Share by Application: 2025 vs 2032
 Figure 10. Hospital and Testing Agency Case Studies
 Figure 11. Personal Case Studies
 Figure 12. Lyme Disease Testing Report Years Considered
 Figure 13. Global Lyme Disease Testing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Lyme Disease Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Lyme Disease Testing Market Share by Region: 2025 vs 2032
 Figure 16. Global Lyme Disease Testing Market Share by Players in 2025
 Figure 17. Global Lyme Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Lyme Disease Testing Revenue in 2025
 Figure 19. North America Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Lyme Disease Testing Market Share by Country (2021–2032)
 Figure 21. United States Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Lyme Disease Testing Market Share by Country (2021–2032)
 Figure 25. Germany Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Lyme Disease Testing Market Share by Region (2021–2032)
 Figure 33. China Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Lyme Disease Testing Market Share by Country (2021–2032)
 Figure 41. Mexico Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Lyme Disease Testing Market Share by Country (2021–2032)
 Figure 45. Israel Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Lyme Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Quidel Corporation Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 49. Roche Holding AG Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 50. Fujirebio(H.U. Group Holdings) Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 51. ZEUS Scientific Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 52. IGeneX Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 54. Everlywell Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 55. Oxford Immunotec Global PLC(PerkinElmer) Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 56. BioMerieux Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 58. T2 Biosystems Revenue Growth Rate in Lyme Disease Testing Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI